Target intelligence / Profile preview

Corneal and tear film mucins (MUCs) (MUCs)

Target
MUCs
Molecular classification
Glycoprotein, Mucin family
01

Overview

Corneal and tear film mucins are high-molecular-weight, heavily glycosylated proteins that are essential for maintaining the stability and health of the ocular surface (Gipson, 2004). They are divided into two main classes: membrane-associated mucins (MUC1, MUC4, and MUC16), which form the glycocalyx on the corneal and conjunctival epithelium, and secreted mucins (primarily MUC5AC), which are produced by conjunctival goblet cells (Mantelli & Argüeso, 2008). These mucins provide lubrication, facilitate the spread of the tear film, and act as a protective barrier against pathogens and environmental stressors (Dartt, 2004). In diseases such as dry eye (keratoconjunctivitis sicca) and Sjögren's syndrome, mucin expression is often significantly reduced or altered, leading to tear film instability and epithelial damage (Argüeso et al., 2002). Therapeutic interventions include mucin secretagogues like diquafosol, which stimulates MUC5AC secretion via P2Y2 receptors, and rebamipide, which increases the expression of both membrane-associated and secreted mucins (Koh et al., 2013; Urashima et al., 2004). Additionally, anti-inflammatory treatments like cyclosporine and lifitegrast may indirectly support mucin production by reducing the inflammatory environment that suppresses goblet cell function (Pflugfelder et al., 2008).

Other names
Ocular mucinsMembrane-associated mucinsSecreted mucinsMUC1MUC4MUC16MUC5ACOcular glycocalyx
02

Mechanism of action

Stimulation of mucin secretion from goblet cells and upregulation of membrane-associated mucin expression in corneal and conjunctival epithelial cells to restore tear film stability (Koh et al., 2013; Urashima et al., 2004).

03

Biological functions

LubricationHydrationBarrier functionPathogen trappingTear film stability
04

Disease associations

Dry eye diseaseKeratoconjunctivitis siccaSjögren's syndromeOcular surface inflammationVitamin A deficiency
05

Safety considerations

Ocular irritationBlurred visionForeign body sensationHypersensitivity reactions
06

Interacting drugs

Rebamipide

4 more in the full profile.

07

Biomarkers

MUC5AC concentration in tearsTear film break-up time (TFBUT)Rose Bengal stainingLissamine Green staining

Beyond the preview

Go deeper on Corneal and tear film mucins (MUCs) (MUCs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal and tear film mucins (MUCs) (MUCs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call